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In this issue of Structure, Lecoq et al. investigated the structural and dynamic basis for the unexpected inhi-
bition of peptidoglycan-crosslinking L,D-transpeptidases by carbapenem antibiotics. In addition to defining
a neutral thiol-imidazole catalytic triad, their studies revealed extensive induced motions upon formation
of a long-live covalent drug-enzyme complex.The major pathway for bacterial peptido-
glycan biosynthesis requires the forma-
tion of peptide-crosslinks catalyzed by
penicillin-binding proteins (PBPs) with
D,D-transpeptidase activity. Due to their
resemblance to the terminal D-Ala-D-Ala
motif present in the precursor stem
pentapeptides, the b-lactam antibiotics
are effective suicide inhibitors of
D,D-transpeptidases. However, in some
bacteria, L,D-transpeptidases bypass this
classical pathway by catalyzing the
formation of alternative peptidoglycan
cross-links from variant stem peptides
lacking a D-Ala-D-Ala motif (Figure 1A)
(Mainardi et al., 2005). Most notably,
L,D-transpeptidation is the predominant
mode of cross-linking in Mycobacterium
tuberculosis (Gupta et al., 2010). The
D,D-transpeptidases and L,D-transpepti-
dases are structurally unrelated and
exploit invariant serine or cysteine resi-
dues, respectively, for catalysis. As
expected from their distinct substrate
specificities, L,D-transpeptidases are in-
sensitive to most b-lactams. However
b-lactams of the carbapenem class,
such as imipenem, are surprisingly active
against these bypass enzymes (Mainardi
et al., 2007). Understanding this activity
may facilitate development of antibacte-
rial strategies targeting L,D-transpepti-
dases, including those in extensively
drug-resistant strains of M. tuberculosis.
Lecoq et al., 2012 (in this issue of
Structure) have used a battery of NMR
spectroscopic techniques to investigate
the structural and dynamic properties of
apo and imipenem-bound L,D-transpepti-
dase from Bacillus subtilis (LdtBS) and to
characterize its Cys-His-Gly catalytic
triad. It must be stressed that, while
crucial for understanding kinetic mecha-
nisms, it is very difficult to determine theionization states and hydrogen bonding
patterns of the active site residues in
enzymes. For example, histidine, which
has the highest propensity among all
amino acids to be involved in catalysis,
can exist in the cationic or neutral Nd1 or
Nε2 tautomeric states. Fortunately, each
of these states has very diagnostic
chemical shift patterns, allowing Lecoq
et al. (2012) to unambiguously establish
that His126 of LdtBS has an unusually
depressed pKa < 3.1 (over 3.5 log units
lower than the average protein value
[Grimsley et al., 2009]) and exists as the
less common neutral Nd1 tautomer under
physiological conditions. Furthermore,
Cys142 does not titrate between pH 3
and 10, and thus has a pKa outside these
limits. Based on a careful structural
analysis of apo LdtBS, Lecoq et al. (2012)
convincingly demonstrated that Cys142
remains protonated under neutral pH
conditions (hence its pKa > 10.5 or over
3.5 log units above average) and
hydrogen bonds to the Nε2 of His126.
The third component of the catalytic
triad, Gly127, serves as a hydrogen
bond acceptor for the histidine Nd1H
through its backbone carbonyl. Thus, in
contrast to the generally accepted thio-
late-imidazolium (S/NH+) ion pair found
in the active site of the prototypical
cysteine protease papain (Lewis et al.,
1981), LdtBS exploits a neutral, hydrogen
bonded thiol-imidazole pair (SH/N) for
catalysis (Figure 1B). Although mecha-
nistic variations can be proposed, by
analogy with serine proteases, His126
likely serves as a general base to activate
the Cys142 Sg for nucleophilic attack
upon the donor peptide carbonyl and
then subsequently as a general acid to
protonate the nitrogen leaving group.
Why are the pKa values of His126 andStructure 20, May 9, 2012Cys142 perturbed to favor their neutral
states and why has nature evolved this
configuration to catalyze peptidoglycan
crosslinking? The answer may lie with
the burial of the histidine, the electroposi-
tive nature of the LdtBS active site, or the
need to protect the cysteine from oxida-
tion in the periplasm. However, rational-
izing the ionization states and hence
precise catalytic functions of active site
residues remains even more challenging
than their experimental characterization.
Lecoq et al. (2012) also uncovered
a striking example of induced dynamics
in the long-lived imipenem-bound state
of LdtBS (Figure 1B). The first clue to
the altered mobility of residues near the
active site of the complex came from
the observed attenuation of their NMR
signals. This hampered the measurement
of NMR-derived restraints for many of
these residues, as well as the bound
imipenem, thus resulting in high root
mean square deviations for the drug and
for flanking active site regions in the
calculated structural ensemble of the
covalently-modified enzyme. However,
this conformational disorder is not a
trivial result of limited experimental data,
but rather results from true dynamics.
Using relaxation-dispersion experiments,
which sensitively detect ms-ms timescale
exchange between conformational states
with different chemical shifts, Lecoq et al.
(2012) demonstrated that the active site
regions of imipenem-bound LdtBS (but
not apo LdtBS) undergo significant
motions with exchange rate constants of
2 ms1. This is not due to loss of the
His126-Cys142 hydrogen bond because
the C142A variant did not show such
dynamic behavior. Rather, the induced
motions result from the covalent modifi-
cation of the enzyme since similar regionsª2012 Elsevier Ltd All rights reserved 753
Figure 1. Inhibition of Bypass Peptidoglycan Biosynthesis by Carbapenems
(A) Mechanism of L,D-transpeptidase catalyzed peptidoglycan crosslinking (m-Dap,meso-diaminopimelic
acid).
(B) The ionization states and hydrogen bonding configuration of the LdtBS Gly-His-Cys catalytic triad and
induced dynamics upon Cys142 acylation by imipenem.
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moiety attached to Cys142 also displayed
ms timescale conformational exchange.
The reasons for these induced motions
remain unclear, as Cys142 is accessible
in the apo enzyme and the bound imipe-
nem does not appear to cause any steric
conflicts in the calculated structural
ensemble. However, this is somewhat
complicated by the lack of experimental
restraints involving the drug and high-
lights the need for additional studies
directed toward understanding the struc-
tural properties of the ‘‘invisible’’ confor-
mational states formed in the detected
exchange equilibria (Baldwin and Kay,
2009). More importantly, are these
motions catalytically-relevant, perhaps
facilitating the second step of the trans-
peptidation reaction (Figure 1A), or are
they somehow specific to the two long-
lived complexes characterized in this754 Structure 20, May 9, 2012 ª2012 Elseviestudy? Addressing this difficult question
will certainly require detailed structural
and dynamic characterization of the
donor thioester enzyme intermediate (or
a close stable analog) that reacts with
the acceptor peptide to form a peptido-
glycan crosslink.
The overarching goal of the Lecoq
et al. (2012) study was to understand
the surprising reactivity of carbapenem
antibiotics toward L,D-transpeptidases.
Through kinetic measurements and
NMR-monitored titrations, the authors
found that both imipenem and nonreac-
tive ampicillin bind the active site region
of wild-type or catalytically-inactive
C142A LdtBS with similar, weak (>mM)
affinities. Furthermore, the covalently-
bonded imipenem does not adopt a
well-defined conformation, but rather
induces active site mobility. Thus, reac-
tivity is not due to any specific, highr Ltd All rights reservedaffinity binding interactions in the Michae-
lis or product complexes. Indeed, it has
long been known that b-lactams are
generally effective inhibitors of PBPs not
because they bind tightly, but because
they are reactive acylating agents (Kluge
and Petter, 2010). Therefore, the answer
to this key question must lie with yet
unknown complementary features of
L,D-transpeptidases and carbapenems
that stabilize the transition state for the
chemical step of acylation. Do these
features involve the induced motions
detected in imipenem-bound LdtBS? The
extensive results of the well-crafted
Lecoq et al. (2012) study provide a much
needed foundation for unraveling the
structural and dynamic mechanisms
underlying carbapenem inhibition of
L,D-transpeptidases, as ultimately re-
quired for the development of improved
antibiotics targetting bypass peptido-
glycan biosynthesis.REFERENCES
Baldwin, A.J., and Kay, L.E. (2009). Nat. Chem.
Biol. 5, 808–814.
Grimsley, G.R., Scholtz, J.M., and Pace, C.N.
(2009). Protein Sci. 18, 247–251.
Gupta, R., Lavollay, M., Mainardi, J.L., Arthur, M.,
Bishai, W.R., and Lamichhane, G. (2010). Nat.
Med. 16, 466–469.
Kluge, A.F., and Petter, R.C. (2010). Curr. Opin.
Chem. Biol. 14, 421–427.
Lecoq, L., Bougault, C., Hugonnet, J.-E., Veckerle´,
C., Pessey, O., Arthur, M., and Simorre, J.-P.
(2012). Stucture 20, this issue, 850–861.
Lewis, S.D., Johnson, F.A., and Shafer, J.A. (1981).
Biochemistry 20, 48–51.
Mainardi, J.L., Fourgeaud, M., Hugonnet, J.E.,
Dubost, L., Brouard, J.P., Ouazzani, J., Rice,
L.B., Gutmann, L., and Arthur, M. (2005). J. Biol.
Chem. 280, 38146–38152.
Mainardi, J.L., Hugonnet, J.E., Rusconi, F., Four-
geaud, M., Dubost, L., Moumi, A.N., Delfosse, V.,
Mayer, C., Gutmann, L., Rice, L.B., and Arthur,
M. (2007). J. Biol. Chem. 282, 30414–30422.
